The mouse TCR gamma locus is positively regulated by the transcription factors STAT5 and Runx. While the locus undergoes frequent rearrangements in T lymphocytes, TCR gamma transcription is repressed in alpha beta T cells. This phenomenon, known as TCR gamma silencing, depends on pre-TCR-induced thymocyte proliferation. The molecular basis for TCR gamma silencing, however, is largely unknown. Here, we show that pre-TCR signaling reduces transcription and histone acetylation of the TCR gamma locus irrespective of V-J rearrangements. We also demonstrate that Runx is recruited to E gamma and HsA enhancer elements of the TCR gamma locus, primarily at the CD4(-)CD8(-) double-negative stage and that Runx binding to these elements decreases at later stages of thymocyte development. Importantly, anti-CD3 antibody treatment decreased IL-7R expression levels, STAT5 phosphorylation and recruitment of STAT5 and Runx to E gamma and HsA elements in RAG2-deficient thymocytes, suggesting that pre-TCR signaling triggers reduced binding of STAT5 and Runx to the enhancer elements. Furthermore, we observed that misexpression of STAT5 or Runx in the CD4(+)CD8(+) double-positive cell line DPK induces TCR gamma gene transcription. Finally, we showed that TCR gamma transcription is induced in alpha beta T cells from Runx3 transgenic mice, suggesting that Runx3 counteracts TCR gamma silencing in alpha beta T cells in vivo. Our results suggest that pre-TCR signaling indirectly inactivates TCR gamma enhancers by reducing recruitment of STAT5 and Runx and imply that this effect is an important step for TCR gamma silencing in alpha beta T cells.